Literature DB >> 10363624

Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.

S Yasuda1, S Higashi, M Murakami, Y Tomono, M Kawaguchi.   

Abstract

AIM: This randomized, open-label, crossover study was conducted to evaluate the effect of a single dose of antacid, aluminum and magnesium hydroxide suspension, on pharmacokinetics of rabeprazole in healthy male volunteers. SUBJECTS AND METHODS: Twelve subjects were randomly divided into 6 groups of 2 subjects each, and received 20 mg of rabeprazole either without antacid, concomitantly with antacid, or one hour after administration of antacid in three experimental arms with washout period of one week. The concentrations of rabeprazole in plasma were determined by high performance liquid chromatography.
RESULTS: Rabeprazole was well tolerated at the 20 mg dose level when given with or without antacid. The pharmacokinetic parameters, Cmax, t(max), AUC and t1/2, showed no statistically significant differences when rabeprazole was administered alone, concomitantly with antacid or one hour after antacid administration.
CONCLUSION: No influence of single dose of antacid on pharmacokinetics of rabeprazole was observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363624

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  8 in total

Review 1.  Pharmacokinetic drug interaction profiles of proton pump inhibitors.

Authors:  Henning Blume; Frank Donath; André Warnke; Barbara S Schug
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Key Pharmacokinetic Essentials of Fixed-Dosed Combination Products: Case Studies and Perspectives.

Authors:  Ranjeet Prasad Dash; Rana Rais; Nuggehally R Srinivas
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 4.  Rabeprazole: a review of its use in acid-related gastrointestinal disorders.

Authors:  H D Langtry; A Markham
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 5.  Drug-drug interaction profiles of proton pump inhibitors.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2010-08       Impact factor: 6.447

Review 6.  Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Claudine M Baldwin; Susan J Keam
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

7.  Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2013-05-10       Impact factor: 8.860

Review 8.  Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Authors:  Ralph-Steven Wedemeyer; Henning Blume
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.